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Abstract: Exacerbations of COPD that result in acute respiratory failure requiring intubation 
and mechanical ventilation have high morbidity and mortality. This study is a retrospective 
observational study that compared the outcomes of 237 patients with COPD and acute 
respiratory failure requiring intensive care unit (ICU) admission according to modality of initial 
therapy: mask continuous positive airway pressure (CPAP), medical therapy, or intubation. Of 
the patients treated with CPAP initially, only 16% failed and required intubation compared 
with 62% of those treated medically (p=0.001). The median length of ICU stay was 5 days 
in those treated with CPAP, compared with 7 days for those medically treated, and 8.5 days 
for intubated patients (p=0.001). When compared with mask CPAP, and after adjusting for 
potentially confounding differences, mortality was signiﬁ  cantly higher if patients were 
initially intubated (adjusted odds ratios [OR] 15.7; 95% conﬁ  dence interval [CI] 4.2, 59) 
or given medical therapy (OR 5.1; CI 1.2, 20.8). In COPD patients with acute respiratory 
failure, initial treatment with mask CPAP was associated with signiﬁ  cantly better outcomes 
than other treatment modalities, even after adjusting for potentially confounding differences 
in disease severity.
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Introduction
Severe COPD exacerbations that result in acute respiratory failure requiring intubation 
and mechanical ventilation are associated with mortality of 35% in the intensive care 
unit, and total in-hospital mortality of 50% (Anon et al 1999). During these acute 
exacerbations, patients with COPD develop signiﬁ  cant intrinsic positive end expiratory 
pressure (PEEP) (Murciano 1982; Fleury et al 1985). This results in increased 
inspiratory elastic work, which can represent the majority of the total inspiratory 
workload in these patients (Fleury et al 1985; Appendini et al 1996). The application 
of external PEEP has been shown to decrease the work of breathing in patients with 
COPD exacerbations by counterbalancing the effects of intrinsic PEEP (Tobin and 
Lodato 1989; Petrof et al 1990; Ranieri et al 1993; Goldberg et al 1995; Aerts et al 
1997). However, mask CPAP has only been evaluated clinically in two case series: 
one with seven patients with COPD (Miro et al 1993), and the other for only 4 hours 
in 15 patients (de Lucas et al 1993).
In 1989, based upon physiologic studies conducted elsewhere (Smith and Marinii 
1988; Appendini et al 1996), and at this institution (Petrof et al 1990), non-invasive 
mask CPAP was introduced into clinical use for treatment of acute respiratory 
failure in COPD patients admitted to our intensive care unit (ICU). By the late 
1990s, mask CPAP was the most common initial treatment modality (and the only 
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non-invasive respiratory assistance) used for these patients. 
However, after the publication of four randomized trials 
demonstrating beneﬁ  ts of non-invasive bilevel ventilation 
as treatment for acute respiratory failure in COPD patients 
(Bott et al 1993; Brochard et al 1995; Kramer et al 1995; 
Plant et al 2000), this modality increasingly replaced mask 
CPAP after 1995.
The present study examined outcomes of intubation, 
mortality, and length of stay among COPD patients with 
acute respiratory failure managed with mask CPAP between 
1991 and 1995. Outcomes in these patients were compared 
with outcomes of similar patients who were treated with 
medical therapy alone or who were immediately intubated 
in our ICU and to similar patients admitted to the ICU of 
another hospital.
Methods
Study population
Patients were considered to have COPD if they had 
a history of cigarette smoking and after treatment with 
a bronchodilator, their best recorded FEV1 was less than 
70% predicted, and their ratio of FEV1 to FVC was less 
than 0.7. In the absence of lung function measurements, a 
clinical diagnosis of COPD in a smoker or ex-smoker was 
also accepted (ATS guidelines 1995). Acute hypercapneic 
respiratory failure was defined as the acute onset of 
severe shortness of breath, with a pH less than 7.36 and 
PCO2 greater than 45 on arterial blood gas. Patients were 
excluded if they had documented advance directives 
refusing intubation, were admitted to the ICU following 
a cardio-respiratory arrest, or were unconscious on 
presentation.
Design
Three cohorts of COPD patients with acute hypercapneic 
respiratory failure admitted to two ICUs were reviewed. The 
primary analysis compared patients treated initially with 
CPAP with those intubated immediately and with patients 
treated initially with medical therapy only.
In one cohort all COPD patients admitted to a respiratory 
ICU in a tertiary care chest hospital between January 1st, 
1991, and December 31st, 1995, were reviewed. No other 
forms of non-invasive ventilation were used in this ICU at 
that time.
Because of evidence that initial treatment modality 
was confounded with severity of illness in the ﬁ  rst cohort, 
patients treated with CPAP were also compared with all 
patients in two other cohorts who did not have access to 
mask CPAP. The ﬁ  rst comparison cohort was constructed 
to provide a contemporary comparison to minimize 
differences in outcomes due to improvements in medical 
care over the years reviewed. This cohort consisted of all 
COPD patients with acute respiratory failure admitted 
during the same years to a general medical ICU in a general, 
tertiary care hospital. No form of non-invasive respiratory 
assistance (including CPAP) was used in this other ICU 
during those ﬁ  ve years.
The second comparison cohort consisted of all COPD 
patients with acute hypercapneic respiratory failure admitted 
to the same respiratory ICU of the same hospital between 
January 1st, 1985, and December 31st, 1988, prior to any 
clinical use of mask CPAP. This cohort was constructed 
to minimize bias due to inter-institutional differences in 
clinical practice, referral patterns, and selection of patient 
populations. Patients in the two comparison cohorts were 
categorized by the initial treatment modality: medical only, 
or intubation.
Data collection
Using standardized data collection forms, baseline (pre-ICU 
admission) information collected included age, gender, FEV1, 
and use of home oxygen. Etiology of exacerbation was 
deﬁ  ned as: (1) pneumonia – if clinically diagnosed and with a 
new inﬁ  ltrate on chest radiograph, a temperature greater than 
38.5°C, or elevated white blood cell count; (2) pulmonary 
edema – if clinically diagnosed and with supportive chest 
radiograph ﬁ  ndings; or (3) acute bronchitic exacerbation 
if no other speciﬁ  c cause of acute respiratory failure could 
be identiﬁ  ed. Data gathered at the time of ICU admission 
included whether the patient was transferred from inpatient 
wards or the emergency department, arterial blood gas values, 
vital signs, and initial modality of therapy – deﬁ  ned as use 
for at least the ﬁ  rst full hour after ICU admission. Data 
gathered subsequent to the ICU admission included CPAP 
pressure used; medications; arterial blood gases after 1, 6, 12, 
and 24 hours; intubation; length of ICU stay; and all cause 
in-hospital mortality.
CPAP system
The CPAP system used consisted of a tightly applied full 
face mask with an inflatable rim that was connected to a 
continuous high-flow system (approximately 100 L/min 
using a Downs Flow Generator nr 9250,Vital Signs Inc, 
Totowa, NJ, USA). The desired pressure was achieved International Journal of COPD 2006:1(1) 67
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by attaching a spring-loaded threshold valve to the 
respiratory circuit. Patients were usually started at a 
CPAP pressure of 5 cm H2O and increased in increments 
of 2.5 cm to the minimum level at which the patient 
experienced relief of dyspnea. No patient received 
pressures higher than 12.5 cm H2O. There was no formal 
protocol for CPAP initiation or discontinuation. CPAP 
was discontinued when patients were able to tolerate 
prolonged periods off CPAP of 4 hours or more, or they 
required intubation according to the judgment of the 
treating physician.
Data analysis
Baseline and ICU admission characteristics, as well as 
outcomes of patients, were compared according to initial 
treatment modality. Differences were tested for statistical 
significance with analysis of variance or Student’s 
t-tests for continuous variables, and Chi-squared tests for 
categorical variables. Multivariate logistic regression was 
used to estimate the association of secondary intubation 
and death with initial mode of therapy after adjustment 
for potentially confounding differences in patient 
characteristics. Ninety-ﬁ  ve percent conﬁ  dence intervals 
(CI) were estimated for the adjusted odds ratios (OR) as 
suggested by Kleinbaum and Kupper (2002).
Results
Between January 1st, 1991, and December 31st, 1995, 88 
patients with COPD were admitted to the respiratory ICU 
with acute respiratory failure. Of these, 17 patients initially 
received medical treatment only, 22 were intubated imme-
diately, and 49 received mask CPAP, which was very well 
tolerated by 44 (90%) of them. In 5 patients the mask was 
removed within 3 hours because of poor tolerance. None 
of the patients treated with CPAP suffered a pneumothorax, 
or any other complication, such as aspiration. As shown 
in Table 1, the three groups of patients were similar with 
respect to age, gender, and prior use of home oxygen, 
but intubated patients had higher average pre-morbid 
FEV1 values. On the other hand, there appeared to be a 
gradient of severity of acute respiratory failure between 
the three groups. Based on vital signs and arterial blood 
Table 1 Baseline and ICU admission characteristics as well as outcomes of patients with COPD and acute respiratory failure 
admitted to the respiratory ICU in 1991–1995, when CPAP was commonly used as a primary treatment modality
Variables Medical  CPAP  Intubated  p-value
Number of patients  17  49  22 
Baseline characteristics
Age (mean, sd)  64.1  sd 9.0   67.6  sd 8.9   70.3   sd 9.8    ns
Male (N, %)  8    (47%)  26  (53%)  11  50%)    ns
Baseline FEV1 (mean, sd)  0.72  sd 0.2      0.68   sd 0.2  0.87  sd 0.4    0.05
Home O2 (N,  %)  5 (29%)  14 (28%)  6 (27%)    ns
ICU admission characteristics
Cause of exacerbation    
Bronchitis (N, %)       10    (59%)  32   (65%)  12  (54%)
Pulmonary edema        2     (12%)  5    (10%)    5    (23%)
Pneumonia (N, %)     5   (29%)   12   (24%)   5     (23%)    ns 
Transfer from       
Ward (N, %)          3    (18%)  29    (59%)  8    (36%)
Emergency department  14    (82%)  20     (41%)      14   (64%)    0.02
Arterial blood gases      
pH (mean, sd)          7.31      sd 0.05  7.27   sd 0.07    7.16    sd 0.1    <0.0001
PCO2 (mean, sd)  69  sd 14.6     74    sd 19.5   92    sd 24.9    0.0008
Respiratory rate (mean, sd)  31  sd 9.4   33    sd 8  36    sd 7.0    ns
Heart rate (mean, sd)  103    sd 18  113    sd 23  125   sd 20    0.01 
Outcomes 
20 intubation (N, %)  3  (17%)  8    (16%)    Not applicable   ns 
Death (N, %)   1  (5%)   3  (6%)  6   (27%)    0.03
ICU length of stay (mean, sd)  8.5  sd 5.6   5.7    sd 3.4  11.4   sd 6.3      <0.0001
NOTE: 20 intubation is deﬁ  ned as intubated in the ICU after failing medical therapy or CPAP.
Abbreviations Tables 1–5: CPAP, continuous positive airway pressure; FEV1, forced expiratory volume in one second; ICU, intensive care unit; ns, not signiﬁ  cant. International Journal of COPD 2006:1(1) 68
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gases at the time of ICU admission, the CPAP-treated 
group appeared to be more severely ill than the medically 
treated patients, but had similar mortality and secondary 
intubation rates, and shorter length of stay. Patients who 
were intubated were most severely ill, had higher mortality, 
and longer lengths of stay.
Patients treated with CPAP in the respiratory ICU 
had somewhat worse baseline status than the 91 COPD 
patients admitted with acute respiratory failure to the 
general medical ICU, where neither CPAP nor other forms 
of non-invasive ventilation were being used between 
1991 and 1995 (Table 2). Despite this, and despite having 
somewhat better ICU admission blood gases and vital 
signs, the 26 medically treated patients in the general 
ICU were more likely to require intubation, to die, and 
to stay longer in the ICU than the CPAP-treated patients 
in the respiratory ICU. 
Between January 1st, 1985, and December 31st, 1988, 
58 patients with COPD were admitted to the respiratory 
ICU with acute respiratory failure. The 27 patients treated 
medically, and the 31 initially intubated, had remarkably 
similar baseline and ICU admission characteristics as the 
patients treated with CPAP in the same ICU in 1991–1995 
(Table 3). However, secondary intubation for those treated 
medically, as well as mortality and length of stay for all 
patients in 1985–1988, were signiﬁ  cantly worse than for the 
CPAP-treated patients. 
As shown in Table 4, after adjusting for baseline and 
ICU admission characteristics using multivariate analysis, 
initial intubation and medical therapy were associated with 
signiﬁ  cantly increased risk of death compared with CPAP 
therapy. Other factors signiﬁ  cantly associated with mortality 
were older age, lower FEV1, and transfer from an inpatient 
unit, rather than the emergency department. In multivariate 
analysis, failure of initial therapy requiring intubation was 
associated with initial medical therapy (rather than CPAP 
therapy) and transfer from an inpatient unit (after medical 
therapy).
Table 2 Baseline and ICU admission characteristics as well as outcomes of patients with COPD and acute respiratory failure 
admitted to the general medical ICU in another hospital in 1991–1995, compared with patients receiving CPAP in 1991–1995 in the 
respiratory ICU in the chest hospital
 CPAP  Medical  Intubated 
  Respiratory ICU  General medical  General medical 
Variables   (1991–1995)   ICU (1991–1995)    ICU (1991–1995) 
Number of patients  49  26  65
Baseline characteristics
Age (mean, sd)  67.1  sd 8.9   71.4    sd 8.7   69.4    sd 8.5
Male (N %)    26   (53%)    9    (35%)    31  (48%)
Baseline FEV1 (mean, sd)   0.68   sd 0.2  0.86   sd 0.34  **   0.81  sd 0.5 *
Home O2 (N %)  14  (28%)  2   (8%)  14      (21%)   
ICU admission characteristics 
Cause of exacerbation            
Bronchitis (N %)  32  (65%)   20   (77%)  51   (80%)
Pulmonary edema (N %)      5      (10%)  3  (11%)  2   (3%)
Pneumonia (N %)  12      (25%)   3  (11%)    11   (17%)
Transfer from   
Ward (N %)     29   (59%)  12   (46%)     21   (32%)
Emergency department  20  (41%)   14  (54%)  *    44  (68%)  ***
Admission blood gases           
pH (mean, sd)          7.27    sd 0.07  7.31   sd 0.09  7.24     sd 0.1
PCO2 (mean, sd)   74.6  sd 19.5  66.6  sd 23  78.8      sd 27 
Respiratory rate (mean, sd)  33    sd 8  33  sd 10   33     sd 10
Heart rate (mean, sd)  114   sd 23   112    sd 20   116    sd 23
Outcomes
20 intubation (N %)  8  (16%)  14   (52%)  ***   Not  applicable
Deaths (N %)  3   (6%)   5   (18%)  *    23   (35%)  ***
ICU days (mean, sd)  5    (3)     7    (6)   7  (3)  *          
NOTE: 20 intubation: deﬁ  ned as intubated in the ICU after failing medical therapy or CPAP. P-value for test of signiﬁ  cance of differences between medical or intubated 
patients vs CPAP treated group: *p=0.05–0.09 **p<0.01 ***p<0.001.International Journal of COPD 2006:1(1) 69
CPAP in respiratory failure in COPD
Table 3 Baseline and intensive care unit (ICU) admission characteristics as well as outcomes of patients with COPD and acute 
respiratory failure admitted to the respiratory ICU in 1985–1988, compared with patients receiving CPAP in 1991–1995 in the 
same ICU
 CPAP  Medical  Intubated
  Respiratory ICU   Respiratory ICU   Respiratory ICU
Variables (1991–1995)  (1985–1988)  (1985–1988)
Number of patients  49  27  31
Baseline characteristics
Age (mean, sd)  67.1    sd 8.9  68.3  sd 7  70.6   sd 8.3
Male (N, %)    26    (53%)   14    (53%)  17    (56%)
Baseline FEV1 (mean, sd)  0.68    sd 0.2  0.76  sd 0.31    0.68    sd 0.25
Home O2 (N, %)  14    (28%)    11    (41%)   11     (31%)                         
ICU admission characteristics 
Cause of exacerbation       
Bronchitis (N, %)   32      (65%)  13   (48%)  20    (65%) 
Pulmonary  edema (N, %)      5   (10%)  7  (26%)  5    (16%)
Pneumonia (N, %)  12  (25%)  7   (26%)  6      (19%)
Transfer from       
Ward (N, %)      29    (59%)  12    (44%)  21   (68%)
Emergency department (N, %)  20  (41%)  15  (56%)  10          (32%)
Arterial blood gases    
pH (mean, sd)       7.27  sd 0.07   7.29  sd 0.08  7.25     sd 0.07
PCO2 (mean, sd)  74.6  sd 19.5   75  sd 19   83   sd 20 *
Respiratory r  ate (mean, sd)   33  sd 8   33   sd 7   36         sd 8
Heart rate (mean, sd)  114    sd 23  113  sd 22   118       sd 15                                                        
Outcomes
20 intubation (N, %)  8     (16%)  20  (77%)  **    Not applicable   
Death (N, %)  3   (6%)  6  (23%) *  14   (37%)  *** 
ICU length of stay (mean, sd)   5      (3)  8   (9)    12    (9)  ***
NOTE: 20 intubation: deﬁ  ned as intubated in the ICU after failing medical therapy or CPAP.  P-value for test of signiﬁ  cance of differences between medical or intubated 
patients vs CPAP treated group: *p=0.06 **p<0.01 ***p<0.001.
Table 4 Adjusted odds of death or secondary intubation from multivariate logistic regression
  Death Secondary  intubation
Variable    (comparison)  OR        (95% CI)  OR         (95% CI)
Number of patients  (237)a  (119)a
Older age (per increase of 5 years)  1.2  (1.0, 1.5)  1.1   (0.8, 1.5)
Gender (male vs female)  2.5  (1.2, 5.0)  1.0   (0.4, 2.7)
Baseline FEV1 (increase of 200 mL)  0.7   (0.5, 0.9)  1.3   ( 0.9, 1.9)
On home oxygen therapy (vs not)  0.7   (0.3, 1.5)  0.6   (0.2, 1.8)
Transfer to ICU from ward (vs from ER)  2.8    (1.4, 5.5)  3.1   (1.1, 8.8)
Initial therapy (medical vs CPAP)  4.8   (1.2, 20.2)  5.6   (1.8, 17)
  (intubated vs CPAP)  14.5  (3.7, 57)  –   –
Lower admission pH (per decrease of 0.05)  1.0   (0.8, 1.2)  1.1   (0.8, 1.4)
ICU (respiratory vs general medical)  0.9   (0.4, 1.8)  0.2   (0.1, 0.8)
a All patients included in analysis of factors associated with mortality, but only patients initially treated with CPAP or medical therapy included in analysis of factors 
associated with secondary intubation (ie, failure of primary therapy).
Abbreviations: CI, conﬁ  dence interval; ER, emergency room; OR, odds ratio.
Eight patients failed CPAP and were intubated: 4 after 
1–2 hours, and the remainder after 12–24 hours. CPAP 
failure was associated with pneumonia, less improvement 
in tachycardia and arterial blood gas abnormalities after one 
hour of CPAP (Table 5), and poor tolerance. Three of the 
5 (60%) who could not tolerate CPAP required intubation, International Journal of COPD 2006:1(1) 70
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Table 5 Baseline and ICU admission characteristics as well as course in ICU among patients treated with CPAP: comparing those 
who required intubation (failed CPAP) with those who did not (success)
Variables  Failed CPAP  CPAP success  p-value
Number of patients  8  41 
Baseline characteristics
Age  65.1 sd  8  68.1 sd  9    ns
Male       6   (75%)  20   (49%)    ns
Baseline FEV1   0.75       sd 0.26   0.67  sd 0.22    ns
Home oxygen therapy  2   (25%)  12  (29%)    ns
ICU admission characteristics
Cause of respiratory failure       3   (37%)  29    (70%)
Bronchitis       0    5  (13%) 
Pulmonary edema    5   (62%)   7   (17%)    0.02 
Pneumonia
Transfer to ICU from      
Ward         6   (75%)   21  (51%)
Emergency department  2    (25%)   18    (44%)    ns
Arterial blood gases      
pH          7.3   sd 0.04  7.27  sd 0.07    ns
PCO2   73  sd 22  74   sd 19    ns
Respiratory rate 
Heart rate   34  sd 7  33  sd 8    ns
  119   sd 17                       111   d 23    ns
Course in ICU and outcomes
Did not tolerate CPAP  3   (37%)  2   (5%)    0.025
Change after 1 hour in:      
Arterial pH        –0.02  sd 0.04  0.06   sd 0.01    0.004
Arterial PCO2     +5   sd 8.8     –11.2   sd 10.7    0.005
Respiratory rate   –3    sd 9     –5    sd 6    ns
Heart rate        +2   sd 7  –4   sd 17    ns 
Deaths                           2  (25%)  1  (2.5%)     0.001
compared with 5 of the 44 who did tolerate it (11%). Two 
of the CPAP failures (25%) died, compared with only one 
of the 41 (2.5%) who did not require intubation.
Discussion
As a result of several randomized controlled trials 
demonstrating reduced need for intubation and lower 
mortality (Bott et al 1993; Brochard et al 1995; Kramer 
et al 1995; Angus et al 1996; Plant et al 2000), non-invasive 
bilevel positive pressure ventilation (BIPAP) is now 
considered standard therapy for acute respiratory failure in 
COPD patients. In our experience, mask CPAP was safe, 
well tolerated, and had similar outcomes and effectiveness 
(relative to medical therapy) as the bilevel non-invasive 
ventilation interventions in randomized trials. As well, 
mortality was much lower among CPAP-treated patients 
than intubated patients, after adjustment for potentially 
confounding clinical differences.
Although limited by its retrospective observational 
design, strengths of the study include the examination of all 
patients with COPD and acute respiratory failure treated over 
several years at two hospitals. A large number of potential 
confounders were measured and adjusted for in multivariate 
analysis, ﬁ  ndings were consistent in all patient groups, and 
our results are similar to other published results (Brochard 
et al 1995). Inclusion of COPD patients with all causes of 
acute respiratory failure should enhance generalizability 
(Benson and Hartz 2000). Differences in premorbid and 
acute illness disease severity can be controlled by randomly 
assigning modality, as in published randomized trials, or, if 
measured, can be controlled in the analysis, with multivariate 
techniques. There were signiﬁ  cant differences in patients’ 
characteristics, particularly in the cohort with access to 
mask CPAP, reﬂ  ecting selection of modality according to 
disease severity. Multivariate analysis was therefore used 
to estimate the effect of CPAP after controlling for other 
variables associated with mortality, such as age (Heuser 
et al 1992), baseline FEV1 (Menzies et al 1989), severity 
of presentation (Portier 1992), and location prior to ICU 
admission (Seneff et al 1995). Even with this adjustment, International Journal of COPD 2006:1(1) 71
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outcomes were consistently better among the patients treated 
with non-invasive CPAP ventilation compared with patients 
in all 3 cohorts who were initially treated with medical 
therapy or were intubated.
The CPAP-treated patients in this study had very similar 
baseline and ICU admission characteristics as the patients 
randomized to non-invasive ventilation in the largest 
previously published trials (Brochard et al 1995; Plant 
et al 2000). In these same studies, mortality and secondary 
intubation rates in the intervention groups were 9% and 
26% (Brochard et al 1995), and 10% and 15%, respectively 
(Plant et al 2000), which are very similar to the rates of 
mortality and intubation among the CPAP-treated patients. 
From a meta-analysis, non-invasive bilevel ventilation was 
associated with signiﬁ  cantly lower rates of intubation (OR 
0.12; 95% CI 0.05–0.29) (Keenan 2000) and lower mortality 
(meta-analysis – OR 0.22; CI 0.09–0.54) (Keenan et al 1997), 
compared with medical therapy alone. These improvements 
in outcomes relative to medically treated patients are also 
similar to the adjusted odds ratios in CPAP treated patients 
in this study.
Nevertheless, these ﬁ  ndings must be interpreted with 
caution because of several important limitations. These 
include the retrospective design, the time period of study, 
potential selection bias, and differences in outcomes due to 
temporal or inter-institutional differences in patients and/
or their care. The retrospective design meant that certain 
factors may have been associated with outcomes because 
they inﬂ  uenced outcomes and were not truly independent 
predictors. For example, the association of CPAP failure 
with worse arterial pH after one hour may have reﬂ  ected the 
direct inﬂ  uence these blood gas results had on the physicians’ 
decision to intubate.
In the respiratory ICU between 1991 and 1995, the 
decision to use CPAP was not made randomly, but rather 
patients were carefully selected. This is evident from the 
differences in ICU admission blood gases and vital signs. 
This was why CPAP-treated patients were also compared with 
patients treated in the same years at another ICU in a different 
hospital where CPAP was not available. Although such a 
comparison might be hampered by systematic differences 
in the patient populations, the clinical characteristics of the 
two groups of patients were very similar. However, other 
inter-institutional differences, such as the threshold for 
intubation, or experience in the care of COPD patients, were 
not measured and may have also inﬂ  uenced outcomes. This 
problem was addressed by use of a historical comparison 
population, ie, patients admitted to the same respiratory ICU 
in earlier years. This approach also has limitations because 
mortality from acute respiratory failure in COPD patients 
decreased over the ten years spanned by this study (Weiss 
and Hudson 1994). Therefore, some of the apparent beneﬁ  t 
of CPAP could have been due to other changes in treatment 
between 1985–1988 and 1991–1995, such as decreased use 
of theophylline and increased use of gastric protection.
In the previously published studies of non-invasive 
ventilation (Bott et al 1993; Brochard et al 1995; Kramer 
et al 1995; Angus et al 1996; Plant et al 2000), patients who 
were intubated were excluded and their outcomes were not 
reported. The ﬁ  nding that mask CPAP had substantially 
lower mortality than intubated patients, after adjustment for 
markers of severity of acute illness, is of considerable interest. 
This suggests intubation may confer an added risk for worse 
outcomes in this population. 
CPAP alone is effective for acute pulmonary edema 
(Bersten et al 1991) and was effective in this study for the few 
patients with COPD who also had pulmonary edema. In one 
study of patients with acute hypoxemic respiratory failure, 
CPAP did not appear to improve outcomes compared with 
oxygen only (Delclaux et al 2000). In another randomized 
controlled trial among 101 patients with various causes of 
acute respiratory failure, outcomes with CPAP or BIPAP were 
similar (Cross et al 2003). Also in two randomized controlled 
trials in patients with pulmonary edema there was no beneﬁ  t 
of BIPAP over CPAP (Brochard et al 1995; Kramer et al 
1995; Mehta et al 1997; Bellone et al 2005). A randomized 
trial comparing mask CPAP with other forms of non-invasive 
ventilation in COPD would be of great interest. This could 
clarify the mode of non-invasive respiratory assistance that 
is best tolerated, simplest, and most cost-effective for COPD 
patients with acute respiratory failure.
Given the evidence of safety, tolerability, and effectiveness 
of other forms of non-invasive ventilation (Meduri et al 1996; 
Keenan et al 1997, 2000; Sinuff et al 2000), what might be 
the potential advantages of CPAP? Mask CPAP is simple 
to administer, requires no synchronization of machine to 
patient, and the equipment is inexpensive. In our setting, 
the equipment for mask CPAP costs less than Can$1000, 
compared with $10 000–$20 000 for BIPAP equipment such 
as the BIPAP Vision (Respironics, CA, USA). It is important 
to point out that the CPAP system used in this study differed 
from the CPAP systems used for patients with obstructive 
sleep apnea. 
In summary, CPAP applied non-invasively was tolerated 
in 90% of patients and had no major complications. After 
adjustment for potential confounders, this approach was International Journal of COPD 2006:1(1) 72
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associated with signiﬁ  cantly reduced rates of intubation and 
mortality in COPD patients with acute respiratory failure. 
In these patients, mask CPAP may be a useful alternative 
mode of non-invasive respiratory assistance.
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